Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure

Author:

Melgarejo Jesus D.12,Yang Wen-Yi13,Thijs Lutgarde1,Li Yan4ORCID,Asayama Kei56ORCID,Hansen Tine W.7ORCID,Wei Fang-Fei1,Kikuya Masahiro5ORCID,Ohkubo Takayoshi56ORCID,Dolan Eamon8,Stolarz-Skrzypek Katarzyna9,Huang Qi-Fang4ORCID,Tikhonoff Valérie10ORCID,Malyutina Sofia11,Casiglia Edoardo10ORCID,Lind Lars12,Sandoya Edgardo13ORCID,Filipovský Jan14,Gilis-Malinowska Natasza15,Narkiewicz Krzysztof15ORCID,Kawecka-Jaszcz Kalina9,Boggia José16ORCID,Wang Ji-Guang4ORCID,Imai Yutaka6,Vanassche Thomas17,Verhamme Peter17ORCID,Janssens Stefan18,O’Brien Eoin19,Maestre Gladys E.21020ORCID,Staessen Jan A.121ORCID,Zhang Zhen-Yu1,Seidlerová J.,Tichá M.,Ibsen H.,Jeppesen J.,Rasmussen S.,Torp-Pedersen C.,Pizzioli A.,Hashimoto J.,Hoshi H.,Inoue R.,Metoki H.,Obara T.,Satoh H.,Totsune K.,Adamkiewicz-Piejko A.,Cwynar M.,Gąsowski J.,Grodzicki T.,Lubaszewski W.,Olszanecka A.,Wizner B.,Wojciechowska W.,Zyczkowska J.,Nikitin Y.,Pello E.,Simonova G.,Voevoda M.,Andrén B.,Berglund L.,Björklund-Bodegård K.,Zethelius B.,Bianchi M.,Moreira V.,Schettini C.,Schwedt E.,Senra H.

Affiliation:

1. From the Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.D.M., W.-Y. Y, L.T., F.-F.W., J.A.S., Z.-Y.Z.)

2. Laboratory of Neurosciences, Faculty of Medicine, University of Zulia, Maracaibo, Venezuela (J.D.M., G.E.M)

3. Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China (W.-Y.Y.)

4. Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., Q.-F.H., J.-G.W.)

5. Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., M.K., T.O.)

6. Tohoku Institute for Management of Blood Pressure (K.A., T.O., Y.I.)

7. Steno Diabetes Center Copenhagen, Gentofte and Research Centre for Prevention and Health, Capital Region of Denmark (T.W.H.)

8. Stroke and Hypertension Unit, Blanchardstown, Dublin, Ireland (E.D.)

9. First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland (K.S.-S., K.K.-J.)

10. Department of Medicine, University of Padova, Italy (V.T., E.C.)

11. Institute of Internal and Preventive Medicine, Internal and Preventive Medicine - Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Science, Novosibirsk, Russian Federation (S.M.)

12. Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Sweden (L.L.)

13. Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.)

14. Faculty of Medicine, Charles University, Pilsen, Czech Republic (J.F.)

15. Department of Hypertension, Medical University of Gdańsk, Poland (N.G.-M., K.N.)

16. Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.)

17. Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (T.V., P.V.)

18. Division of Cardiology, Department of Internal Medicine, University Hospitals Leuven, Belgium (S.J.)

19. Conway Institute, University College Dublin, Ireland (E.O.)

20. Alzheimer’s Disease Resource Center for Minority Aging Research, University of Texas Rio Grande Valley, Brownsville (G.E.M.)

21. Research Institute Alliance for the Promotion of Preventive Medicine, Mechelen, Belgium (J.A.S.).

Abstract

Major adverse cardiovascular events are closely associated with 24-hour blood pressure (BP). We determined outcome-driven thresholds for 24-hour mean arterial pressure (MAP), a BP index estimated by oscillometric devices. We assessed the association of major adverse cardiovascular events with 24-hour MAP, systolic BP (SBP), and diastolic BP (DBP) in a population-based cohort (n=11 596). Statistics included multivariable Cox regression and the generalized R 2 statistic to test model fit. Baseline office and 24-hour MAP averaged 97.4 and 90.4 mm Hg. Over 13.6 years (median), 2034 major adverse cardiovascular events occurred. Twenty-four-hour MAP levels of <90 (normotension, n=6183), 90 to <92 (elevated MAP, n=909), 92 to <96 (stage-1 hypertension, n=1544), and ≥96 (stage-2 hypertension, n=2960) mm Hg yielded equivalent 10-year major adverse cardiovascular events risks as office MAP categorized using 2017 American thresholds for office SBP and DBP. Compared with 24-hour MAP normotension, hazard ratios were 0.96 (95% CI, 0.80–1.16), 1.32 (1.15–1.51), and 1.77 (1.59–1.97), for elevated and stage-1 and stage-2 hypertensive MAP. On top of 24-hour MAP, higher 24-hour SBP increased, whereas higher 24-hour DBP attenuated risk ( P <0.001). Considering the 24-hour measurements, R 2 statistics were similar for SBP (1.34) and MAP (1.28), lower for DBP than for MAP (0.47), and reduced to null, if the base model included SBP and DBP; if the ambulatory BP indexes were dichotomized according to the 2017 American guideline and the proposed 92 mm Hg for MAP, the R 2 values were 0.71, 0.89, 0.32, and 0.10, respectively. In conclusion, the clinical application of 24-hour MAP thresholds in conjunction with SBP and DBP refines risk estimates.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3